Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Asset Utilization Ratio: 2018-2025

Historic Asset Utilization Ratio for Rocket Pharmaceuticals (RCKT) over the last 8 years, with Sep 2025 value amounting to -0.00.

  • Rocket Pharmaceuticals' Asset Utilization Ratio fell 6.93% to -0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.00, marking a year-over-year decrease of 6.93%. This contributed to the annual value of -0.00 for FY2024, which is 2.80% down from last year.
  • Rocket Pharmaceuticals' Asset Utilization Ratio amounted to -0.00 in Q3 2025, which was down 13.18% from -0.00 recorded in Q2 2025.
  • Rocket Pharmaceuticals' 5-year Asset Utilization Ratio high stood at -0.00 for Q4 2023, and its period low was -0.01 during Q1 2021.
  • In the last 3 years, Rocket Pharmaceuticals' Asset Utilization Ratio had a median value of -0.00 in 2023 and averaged -0.00.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first spiked by 70.69% in 2022, then declined by 27.19% in 2024.
  • Quarterly analysis of 5 years shows Rocket Pharmaceuticals' Asset Utilization Ratio stood at -0.01 in 2021, then surged by 33.73% to -0.00 in 2022, then climbed by 16.20% to -0.00 in 2023, then dropped by 27.19% to -0.00 in 2024, then declined by 6.93% to -0.00 in 2025.
  • Its last three reported values are -0.00 in Q3 2025, -0.00 for Q2 2025, and -0.00 during Q1 2025.